News

Fifth issued patent in the U.S. for QTORINâ„¢ rapamycin with anticipated patent life extending into 2038QTORINâ„¢ rapamycin has the potential to be ...
Natural Grocers®, the leading family-operated organic and natural grocery retailer in the U.S., invites Nebraska customers to ...
EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ — Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary, ...
SEATTLE, WA / ACCESS Newswire / April 21, 2025 / Aptevo Therapeutics Inc. (Nasdaq:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology ...
Circle Pharma, a clinical-stage biopharmaceutical company focused on developing cell-permeable macrocycle therapeutics, today announced a late-breaking poster presentation at the American Association ...
South Korea-based DAAN Biotherapeutics has entered a licensing agreement with GC Cell, granting the latter exclusive rights ...
Ahead of AACR 2025, Charles River announces updates to its comprehensive portfolio to support the discovery and development of novel oncology drugs.
Shares of Iovance Biotherapeutics have plummeted post-Amtagvi approval. Read more to see a full investment analysis for IOVA ...
Driven by a clear and impactful mission, ZeroHarm Sciences is committed to enhancing the efficacy and reach of natural wellness. This is achieved through the meticulous formulation of plant-based, ...
Healthcare is ever-changing, as it has been for decades. Sometimes, these changes are for the better, while other times, they may be for the worse. Becker’s connected with several physicians across a ...
Multiple pharmaceutical agents in clinical trials promise to offer patients eye drops for the management of presbyopia.